IBS agrees to buy QuantumCompute to enter AI chip design

Hong Kong-listed International Business Settlement Holdings has agreed to buy QuantumCompute Solutions, seeking an entry into AI chip design alongside its fintech and computing power services. Announced on October 30, 2026, the proposed acquisition would give IBS indirect control of Shanghai Tianjing Fulian, a designer focused on low-power AI computing. The transaction remains subject to completion.

The chip business sits one company down

The agreement covers all of QuantumCompute Solutions, rather than a direct purchase of the Shanghai chip designer. QuantumCompute indirectly owns approximately 85.94% of Shanghai Tianjing Fulian. If the deal closes, QuantumCompute would become a wholly owned IBS subsidiary, and its financial results would enter the group’s consolidated accounts.

Shanghai Tianjing Fulian designs and develops AI system-on-chip, or SoC, products and integrated solutions. IBS’s announcement describes a focus on low-power, cost-effective AI computing and edge computing applications, with capabilities in AI inference and edge-side computing infrastructure. Those are the operating capabilities behind the proposed purchase, rather than a new chip launch.

The business also has established semiconductor-industry relationships. According to IBS’s announcement, Shanghai Tianjing Fulian is an officially authorised independent chip design house for MediaTek. Foxconn Industrial Internet owns another 5.56% of the Shanghai company. The proposed transaction concerns QuantumCompute’s interest; it is not an agreement to buy the Foxconn Industrial Internet stake.

Two different prices appear in public accounts

IBS’s October 30 announcement, distributed by Media OutReach Newswire and published by Macau Business, puts the consideration at HK$563 million. The page identifies the material as a corporate news release and states that the issuer is responsible for its content. That makes the figure an explicit company disclosure, rather than an independently assessed valuation.

DealStreetAsia’s November 1 account instead lists HK$463 million, while also describing a purchase of QuantumCompute’s entire equity interest. The two accounts therefore disagree on a material deal term, not on whether IBS signed an acquisition agreement. The conflicting figures cannot be reconciled here; HK$563 million is the amount stated in the company-issued announcement.

Buying capabilities instead of building them

IBS’s rationale is to acquire a functioning design business, its specialised technical staff and its technology assets together. The board says buying those capabilities should shorten development time compared with creating them internally. It presents the acquisition as a faster route into AI semiconductors and edge computing, not simply an addition to its investment holdings.

The intended business would span computing infrastructure, AI chips and AI application solutions. IBS links that ambition to demand for low-latency, real-time AI computing. The transaction would supply the chip-design component of that strategy; creating the wider integrated business remains the company’s stated objective, rather than an outcome already delivered by the agreement.